Chairman : Dr. Raj Vardhan Azad
Moderator : Dr. Anand Vinekar
PANELISTS
Dr. Subhadra Jalali, Dr. Mangat Dogra, Dr. Pramod Bhende, Dr. Karobi Lahiri, Dr. Vasumathy Vedantham, Dr. Parag Shah, Dr. V Narendran, Dr. Sucheta Kulkarni and Dr. Parijat Chandra
GUEST LECTURE :
Anti VEFG in ROP – An Overview – (10 mins.) : Dr. Lingam Gopal
Anti VEGF in ROP – Questions – ( 50 mins. ) : Panel Members
1. How do We Interpret Beat ROP ?
2. Where Does Macugen Stands Today?
3. What are the Main Issues with Bevacizumab?
a) Dose b) Half life c) Mol Wt d) Retention in circulation e) Morbidity f) Mortality g) Efficacy
4. How is Ranibizumab Placed ?
a) Dose b) Half life c) Mol Wt d) Retention in circulation e) Morbidly f) Mortality g) Efficacy
5. Do We have Any Other Pharmacological Agents Other than VegF——IGF-1
a) What is it’s role? b) How does it work ? c) When should we use it?
d) Efficacy
Open House : 30 minutes
Leave a Comment